Your browser doesn't support javascript.
loading
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D2) in patients with advanced cancer.
Wisinski, Kari B; Ledesma, Wendy M; Kolesar, Jill; Wilding, George; Liu, Glenn; Douglas, Jeffrey; Traynor, Anne M; Albertini, Mark; Mulkerin, Daniel; Bailey, Howard H.
Afiliação
  • Wisinski KB; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA kbwisinski@medicine.wisc.edu.
  • Ledesma WM; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Kolesar J; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Wilding G; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Liu G; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Douglas J; Department of Statistics, University of Illinois at Urbana-Champaign, Urbana, IL, USA.
  • Traynor AM; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Mulkerin D; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
  • Bailey HH; UW School of Medicine and Public Health, University of Wisconsin (UW) Carbone Cancer Center, Madison, WI, USA.
J Oncol Pharm Pract ; 21(6): 416-24, 2015 Dec.
Article em En | MEDLINE | ID: mdl-24986793

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ergocalciferóis / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ergocalciferóis / Neoplasias / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Oncol Pharm Pract Assunto da revista: FARMACIA Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos